(Q36441455)

14 August 2017

1 reference

title

Moxonidine: a review of its use in essential hypertension (English)

1 reference

Katherine A Lyseng-Williamson

14 August 2017

author

series ordinal

3

object named as

Katherine A Lyseng-Williamson

1 reference

14 August 2017

2

Gillian M Keating

1 reference

14 August 2017

Caroline Fenton

1

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

66

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

477-496

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200666040-00006

14 August 2017

exact match

0 references

cites work

Chronic I(1)-imidazoline agonism : sympathetic mechanisms in hypertension.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200666040-00006

Impact of current and past blood pressure on retinal arteriolar diameter in an older population

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200666040-00006

Different effects of losartan and moxonidine on endothelial function during sympathetic activation in essential hypertension

21 January 2018

1 reference

12 December 2020

Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States

1 reference

12 December 2020

The effects of imidazoline agents on the aggregation of human platelets

1 reference

12 December 2020

Comparison of the antihypertensive efficacy of and tolerance to 2 imidazoline receptor agonists: moxonidine and rilmenidine in monotherapy

1 reference

12 December 2020

Moxonidine improves insulin sensitivity in insulin-resistant hypertensives

1 reference

12 December 2020

Quinidine does not affect the renal clearance of moxonidine

1 reference

12 December 2020

Insulin resistance and sympathetic overactivity in women

1 reference

12 December 2020

Hypertension guidelines, meta-analyses and clinical trials: do we assume too much?

1 reference

12 December 2020

Antihypertensive therapy and new onset diabetes

1 reference

12 December 2020

Treatment of postmenopausal hypertension with moxonidine, a selective imidazoline receptor agonist.

1 reference

12 December 2020

Efficacy of moxonidine in the treatment of hypertension in obese, noncontrolled hypertensive patients

1 reference

12 December 2020

New treatment guidelines for a patient with diabetes and hypertension.

1 reference

12 December 2020

Metabolism and disposition of the antihypertensive agent moxonidine in humans

1 reference

12 December 2020

Moxonidine effect on microalbuminuria, thrombomodulin, and plasminogen activator inhibitor-1 levels in patients with essential hypertension

1 reference

12 December 2020

Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study

1 reference

12 December 2020

Hemodynamic and neurohumoral effects of moxonidine in patients with essential hypertension

1 reference

12 December 2020

Intraindividual comparison of moxonidine and prazosin in hypertensive patients

1 reference

12 December 2020

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

12 December 2020

Comparison of moxonidine and clonidine HCl in treating patients with hypertension

1 reference

12 December 2020

Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure

1 reference

12 December 2020

Moxonidine and hydrochlorothiazide in combination: a synergistic antihypertensive effect

1 reference

12 December 2020

Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy

1 reference

12 December 2020

Effect of moxonidine and cilazapril on microcirculation as assessed by finger nailfold capillaroscopy in mild-to-moderate hypertension

1 reference

12 December 2020

Effects of moxonidine vs. metoprolol on blood pressure and metabolic control in hypertensive subjects with type 2 diabetes

1 reference

12 December 2020

[The importance of microcirculation and tissue perfusion in hypertension]

1 reference

12 December 2020

The use of moxonidine in the treatment of hypertension

1 reference

12 December 2020

Central blockade of nitric oxide synthesis reduces moxonidine-induced hypotension

1 reference

12 December 2020

Adverse mortality effect of central sympathetic inhibition with sustained‐release moxonidine in patients with heart failure (MOXCON)

1 reference

12 December 2020

Pharmacology of moxonidine: an I1-imidazoline receptor agonist.

1 reference

12 December 2020

The influence of renal function on clinical pharmacokinetics of moxonidine

1 reference

12 December 2020

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

12 December 2020

Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild-to-moderate essential hypertension

1 reference

12 December 2020

Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist

1 reference

12 December 2020

Moxonidine. A review of its pharmacology, and therapeutic use in essential hypertension

1 reference

12 December 2020

Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild to moderate essential hypertension

1 reference

12 December 2020

Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent progression of diabetic nephropathy?

1 reference

12 December 2020

Pharmacodynamic action and pharmacokinetics of moxonidine after single oral administration in hypertension patients

1 reference

12 December 2020

Moxonidine treatment of hypertensive patients with advanced renal failure

1 reference

12 December 2020

Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease

1 reference

12 December 2020

Use of moxonidine in elderly patients with resistant hypertension

1 reference

12 December 2020

Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful MARRIAGE?

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.

1 reference

12 December 2020

Old antihypertensives and new diabetes

1 reference

12 December 2020

The sympathetic nervous system in hypertension: differing effects of drug treatment

1 reference

12 December 2020

The I1-imidazoline agonist moxonidine decreases sympathetic tone under physical and mental stress

1 reference

12 December 2020

1 reference

12 December 2020

10.2165/00003495-200666040-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

14 August 2017

1013365528

0 references

1 reference